CD28 disruption exacerbates inflammation in Tgf-β1-/- mice: In vivo suppression by CD4+CD25+ regulatory T cells independent of autocrine TGF-β1

Blood

Volumn 103, Issue 12, 2004, Pages 4594-4601

  Mamura, Mizuko ^b   Lee, WoonKyu ^b   Sullivan, Timothy J ^b   Felici, Angelina ^b   Sowers, Anastasia L ^b   Allison, James P ^b   Letterio, John J ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTEGRIN; BETA7 INTEGRIN; CD28 ANTIGEN; CD4 ANTIGEN; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; GLUCOCORTICOID; INTERLEUKIN 2 RECEPTOR; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR RECEPTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOCRINE EFFECT; AUTOIMMUNE DISEASE; CONTROLLED STUDY; FEMALE; GENE DISRUPTION; GENE EXPRESSION; IMMUNOREGULATION; IMMUNOSUPPRESSIVE TREATMENT; IN VIVO STUDY; INFLAMMATION; LYMPH NODE CELL; MALE; MOUSE; MOUSE STRAIN; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY MECHANISM; SPLEEN CELL; T LYMPHOCYTE;

EID: 2942627115     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood-2003-08-2897     Document Type: Article

References (33)

1. Letterio JJ, Roberts AB. Regulation of immune responses by TGF-β. Annu Rev Immunol. 1998;16:137-161.
2. Gorelik L, Flavell RA. Transforming growth factor-β in T-cell biology. Nat Rev Immunol. 2002;2:46-53.
3. Kulkami AB, Huh CG, Becker D, et al. Transforming growth factor β 1 null mutation in mice causes excessive inflammatory response and early death. Proc Natl Acad Sci U S A. 1993;90:770-774.
4. Shull MM, Ormsby I, Kier AB, et al. Targeted disruption of the mouse transforming growth factor-β 1 gene results in multifocal inflammatory disease. Nature. 1992;359:693-699.
5. Dang H, Geiser AG, Letterio JJ, et al. SLE-like autoantibodies and Sjogren's syndrome-like lymphoproliferation in TGF-β knockout mice. J Immunol. 1995;155:3205-3212.
6. Christ M, McCartney-Francis NL, Kulkami AB, et al. Immune dysregulation in TGF-β1-deficient mice. J Immunol. 1994;153:1936-1946.
7. Diebold RJ, Eis MJ, Yin M, et al. Early-onset multifocal inflammation in the transforming growth factor beta 1-null mouse is lymphocyte mediated. Proc Natl Acad Sci U S A. 1995;92:12215-12219.
8. Letterio JJ, Geiser AG, Kulkami AB, et al. Autoimmunity associated with TGF-β1-deficiency in mice is dependent on MHC class II antigen expression. J Clin Invest. 1996;98:2109-2119.
9. Kobayashi S, Yoshida K, Ward JM, et al. β2-microglobulin-deficient background ameliorates lethal phenotype of the TGF-β1 null mouse. J Immunol. 1999;163:4013-4019.
10. Gorelik L, Flavell RA. Abrogation of TGF-β signaling in T cells leads to spontaneous T cell differentiation and autoimmune disease. Immunity. 2000;12:171-181.
11. Lucas PJ, Kim SJ, Melby SJ, Gress RE. Disruption of T cell homeostasis in mice expressing a T cell-specific dominant negative transforming growth factor β II receptor. J Exp Med. 2000;191:1187-1196.
12. Alegre ML, Frauwirth KA, Thompson CB. T cell regulation by CD28 and CTLA-4. Nat Rev Immunol. 2001;1:220-228.
13. + immunoregulatory T cells that control autoimmune diabetes. Immunity. 2000;12:431-440.
14. Shevach EM. Regulatory T cells in autoimmunity. Annu Rev Immunol. 2000;18:423-449.
15. Wood KJ, Sakaguchi S. Regulatory T cells in transplantation tolerance. Nat Rev Immunol. 2003;3:199-210.
16. + regulatory T cells from human peripheral blood. J Immunol. 2001;166:7282-7289.
17. Nakamura K, Kitani A, Strober W. Cell contact-dependent immunosuppression by CD4+CD25+ regulatory T cells is mediated by cell surface-bound transforming growth factor beta. J Exp Med. 2001;194:629-644.
18. Read S, Malmstrom V, Powrie F. Cytotoxic T lymphocyte-associated antigen 4 plays an essential role in the function of CD25(+)CD4(+) regulatory cells that control intestinal inflammation. J Exp Med. 2000;192:295-302.
19. Piccirillo CA, Letterio JJ, Thornton AM, et al. CD4(+)CD25(+) regulatory T cells can mediate suppressor function in the absence of transforming growth factor beta1 production and responsiveness. J Exp Med. 2002;196:237-246.
20. Hori S, Nomura T, Sakaguchi S. Control of regulatory T cell development by the transcription factor Foxp3. Science. 2003;299:1057-1061.
21. Fontenot JD, Gavin MA, Rudensky AY. Foxp3 programs the development and function of CD4+CD25+ regulatory T cells. Nat Immunol. 2003;4:330-336.
22. Khattri R, Cox T, Yasayko SA, et al. An essential role for Scurtin in CD4+CD25+ T regulatory cells. Nat Immunol. 2003;4:337-342.
23. Shahinian A, Pfeffer K, Lee KP, et al. Differential T cell costimulatory requirements in CD28-deficient mice. Science. 1993;261:609-612.
24. Tivol EA, Boyd SD, McKeon S, et al. CTLA-41g prevents lymphoproliferation and fatal multiorgan tissue destruction in CTLA-4 deficient mice. J Immunol. 1997;158:5091-5094.
25. Chambers CA, Sullivan TJ, Allison JP. Lymphoproliferation in CTLA-4-deficient mice is mediated by costimulation-dependent activation of CD4+ T cells. Immunity. 1997;7:885-895.
26. Tang Q, Henriksen KJ, Boden EK, et al. CD28/B7 controls peripheral homeostasis of CD4+CD25+ T regulatory cells. J Immunol. 2003;171:3348-3352.
27. Takahashi T, Tagami, T, Yamazaki S, et al. Immunologic self-tolerance maintained by CD25+CD4+ regulatory T cells constitutively expressing cytotoxic T lymphocyte-associated antigen 4. J Exp Med. 2000;192:303-310.
28. Shimizu J, Yamazaki S, Takahashi T, et al. Stimulation of CD25(+)CD4(+) regulatory T cells through GITR breaks immunological self-tolerance. Nat Immunol. 2002;3:135-142.
29. Lehmann J, Huehn J, de la Rosa M, et al. Expression of the integrin alpha E beta 7 identifies unique subsets of CD25+ as well as CD25-regulatory T cells. Proc Natl Acad Sci U S A. 2002;99:13031-13036.
30. Gavin MA, Clarke SR, Negrou E, et al. Homeostasis and anergy of CD4(+)CD25(+) suppressor T cells in vivo. Nat Immunol. 2002;3:33-41.
31. Gao JX, Zhang H, Bai XF, et al. Perinatal blockade of b7-1 and b7-2 inhibits clonal deletion of highly pathogenic autoreactive T cells. J Exp Med. 2002;195:959-971.
32. Gajewski TF, Fallarino F, Fields PE, Rivas F, Alegre ML. Absence of CTLA-4 lowers the activation threshold of primed CD8+ TCR transgenic T cells: lack of correlation with Src homology domain 2-containing protein tyrosine phosphatase. J Immunol. 2001;166:3900-3907.
33. Piccirillo CA, Shevach EM. Cutting edge: control of CD8+ T cell activation by CD4+CD25+ immunoregulatory T cells. J Immunol. 2001;167:1137-1140.